Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis clinical trial (NCT03945188). Contact the study team or your healthcare provider for specific answers.

Question 2

How does etrasimod compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis clinical trial (NCT03945188). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking etrasimod?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis clinical trial (NCT03945188). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis clinical trial (NCT03945188). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis clinical trial (NCT03945188). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my participation in this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis clinical trial (NCT03945188). Contact the study team or your healthcare provider for specific answers.

What this study is about